As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: March 5, 2012
by Liz Bestic for The Telegraph
Twenty-four years ago, one of the UK’s most notorious pollution disasters occurred. At a water treatment works on the edge of Bodmin Moor, 20 tonnes of aluminium sulphate leaked into the water supply serving the nearby town of Camelford.
Years of bitter disputes followed, with people who had drunk the water complaining of health problems. There were government inquiries, accusations of a cover-up – and, in 2004, the death of Carole Cross. This 58-year-old Camelford resident died from a rare and aggressive form of Alzheimer’s, and her brain was found to contain unusually high levels of aluminium.
The inquest into the cause of Mrs Cross’s death, delayed twice in the past few years, is set to report this week. Among those who will be watching the outcome with interest is Professor Chris Exley, who was called in nearly eight years ago to examine Mrs Cross’s brain (it contained 23 micrograms of aluminium per gram of brain, compared to normal levels of 0‑2mcg).
But Prof Exley, a world-renowned expert on aluminium, hopes the inquest will do more than finally establish the truth about why Mrs Cross died (he is convinced that aluminium from the drinking water played a role in her mental deterioration). He also hopes it will highlight how little we know about the implications for our health of the most prolific metal on the planet.
Aluminium, he argues, is now added to or used in almost everything we eat, drink, inject or absorb. At high levels, it is an established neurotoxin – yet no one knows whether the levels we are ingesting are safe.
Antihypertensive therapy to lower elevated blood pressure (BP) decreases the risk for dementia and Alzheimer’s disease (AD) in older adults, and the benefits may be gained by several different drug classes, new research shows. Debate...
The Alzheimer’s Association estimated the direct cost to American society of Alzheimer’s and other dementias to be $259 billion in 2017. Because of the increasing number of older individuals being diagnosed, there is an ever-increasing need for ways to treat and lower risk of dementia. A...
It’s pretty extraordinary for people in their 80s and 90s to keep the same sharp memory as someone several decades younger, and now scientists are peeking into the brains of these “superagers” to uncover...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.